Rituximab biosimilar in rheumatoid arthritis: an enhanced-evidence assessment to evaluate equivalence with the originator based on network meta-analysis
Ther Adv Musculoskelet Dis
.
2017 Oct;9(10):271-273.
doi: 10.1177/1759720X17721151.
Epub 2017 Aug 23.
Authors
Marco Chiumente
1
,
Andrea Messori
2
Affiliations
1
Scientific Direction, Italian Society for Clinical Pharmacy and Therapeutics, Milan, Italy.
2
Health Technology Assessment Unit, ESTAR Toscana, Regional Health Service, Via San Salvi 12, 50100 Florence, Italy.
PMID:
28974989
PMCID:
PMC5613856
DOI:
10.1177/1759720X17721151
No abstract available